Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia

Completed

• Conditions: Ventilator Associated Pneumonia

• Registration Number: NCT04563104
• Lead Sponsor: Ain Shams University

Brief Summary

Ventilator Associated pneumonia (VAP) is associated with longer ICU length of stay, prolonged mechanical ventilation, and increased use of antimicrobials, health-care cost and mortality . Acute respiratory infections (ARIs) comprise a large and heterogeneous group of infections, including bacterial infections, viral infections, and infections of other etiologies. Early initiation of adequate antibiotic therapy is the cornerstone in the treatment. However, overuse of antibiotics and prolonged duration of antibiotic therapy in patients with bacterial ARIs in the hospital and intensive care setting is associated with increased resistance for common bacteria, high costs, and adverse drug reactions.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-09
• Study First Submitted: 2020-09-09
• Study First Submitted QC: 2020-09-18
• Study First Posted: 2020-09-24
• Study Start: 2020-10-01
• Primary Completion: 2021-08-01
• Study Completion: 2021-09-01
• Last Update Submitted: 2021-09-26
• Last Update Posted: 2021-09-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

• 18 years old or greater
• Ventilator associated pneumonia (VAP) with positive sputum culture.

Read More

Exclusion Criteria

• pregnancy,
• use of immunosuppressive agents except for steroids,
• neutropenia (white blood cell count ≤1000/mL)
• patients whose primary diagnosis was community acquired pneumonia and other source of infection.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
correlation between lung ultrasound and procalcitonin.	7 days

Trial Locations

Locations (1)

Ain Shams University; 🇪🇬 Cairo, Egypt